Effect of demecolcine and nocodazole on the efficiency of chemically assisted removal of chromosomes and the developmental potential of nuclear transferred porcine oocytes

Cloning Stem Cells. 2003;5(4):379-87. doi: 10.1089/153623003772032871.

Abstract

Brief treatment of metaphase II (MII) stage porcine oocytes with 0.4 microg/mL demecolcine in the presence of 0.05 M sucrose produces a membrane protrusion that contains a condensed chromosome mass. The present study examined the optimal conditions for demecolcine and nocodazole treatment in chemically assisted removal of chromosomes. When matured oocytes were treated with 0.1-0.4 microg/mL demecolcine for 60 min or with 0.4 microg/mL demecolcine for 30 min or 3 microg/mL nocodazole for 30 or 60 min, more than 70% of oocytes had a membrane protrusion containing condensed chromosomes were located. There was no difference in the in vitro developmental potential of enucleated oocytes assisted by 0.1 and 0.4 microg/mL demecolcine or 3 microg/mL nocodazole that received porcine somatic cells. After transfer to 10 recipients, however, two of six recipients that received demecolcine-treated enucleated eggs produced four healthy cloned piglets, but none of the four recipients of nocodazole-treated enucleated eggs produced piglets. Further studies are required to increase the successful development to term because the proportion of live piglets was low (4/2, 672, 0.15%).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Nucleus / genetics
  • Cells, Cultured
  • Chromosomes / drug effects*
  • Chromosomes / genetics
  • Cloning, Organism / methods*
  • Demecolcine / pharmacology*
  • Embryo Transfer
  • Embryonic and Fetal Development / drug effects*
  • Female
  • Fertilization in Vitro
  • Male
  • Nocodazole / pharmacology*
  • Oocytes / drug effects*
  • Oocytes / physiology
  • Pregnancy
  • Swine

Substances

  • Antineoplastic Agents
  • Nocodazole
  • Demecolcine